This week, Congress reached a bipartisan healthcare deal as part of a larger $1.2 trillion spending bill, combining funding ...

Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup ...

Alcohol use disorder kills more Americans than opioids or car crashes. Yet for decades, medicine ignored an FDA-approved pill that significantly reduces relapse risk and heavy-drinking days. That pill ...

Frank Vinluan is senior biopharma reporter for MedCity News. He previously held business reporting positions at Xconomy, The Seattle Times, The Des Moines Register, and the Triangle Business Journal.